Skip to main content

Table 1 Thrombolytic therapy

From: NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related thrombosis

Thrombolytic agent

Therapeutic dose

Monitoring

r-TPA

Start: 0.1 mg/kg/h iv

Continuous infusion for longer

periods with increasing doses if

no improvement

Max. dose: 0.5 mg/kg/h iv

Check CBC, APTT, PT, fibrinogen, D-dimers daily

Exclude ICH by US daily

Transfuse with FFP daily

Maintain fibrinogen > 1.0 g/L and platelets > 50 × 109/L

Check thrombus resolution once to twice daily

  1. Abbreviations: r-TPA recombinant tissue plasminogen activator, h hour, iv intravenously, CBC complete blood count, APTT activated partial thromboplastin time, PT prothrombin time, ICH intracranial hemorrhage, US ultrasound, FFP Fresh frozen plasma, max maximum